Fecal calprotectin in healthy children

Abstract Calprotectin is a protein found in the cytosol of inflammatory cells and is a marker of the presence and the degree of inflammation in the bowel system. Calprotectin in feces has great diagnostic value in the matter of inflammatory bowel disease (IBD). In feces, the protein is stable up to seven days, and since the protein can easily be measured with an ELISA, the use of fecal calprotectin (FC) means no invasive measures. For adults and children over 4 years, a cut-off level of 50 mg/kg has been well established for diagnostic purposes. Because previous studies have proven that children under the age of four in general have higher FC values than older children and adults, there is a need for a cut-off level for this age group. In order to establish that, the normal values for FC in children from 0–4 years were investigated. Some 75 stool samples from healthy children were collected and the levels of FC were analyzed. The results were compared to 157 pediatric cases where FC analysis had been performed for diagnostic purposes. As a result, three cut-off levels were established based on the 97.5% percentiles of FC in different age groups: 538 mg/kg (1 < 6 months), 214 mg/kg (6 months < 3 years) and 75 mg/kg (3 < 4 years).

[1]  P. Henderson,et al.  The Diagnostic Accuracy of Fecal Calprotectin During the Investigation of Suspected Pediatric Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis , 2014, The American Journal of Gastroenterology.

[2]  G. Vaos,et al.  Fecal Calprotectin in Pediatric Inflammatory Bowel Disease: A Systematic Review , 2013, Digestive Diseases and Sciences.

[3]  Jing-Long Huang,et al.  Fecal Calprotectin as a Correlative Marker in Clinical Severity of Infectious Diarrhea and Usefulness in Evaluating Bacterial or Viral Pathogens in Children , 2012, Journal of pediatric gastroenterology and nutrition.

[4]  N. Kennedy,et al.  The Diagnostic Accuracy of Fecal Calprotectin During the Investigation of Suspected Pediatric Inflammatory Bowel Disease , 2012, The American Journal of Gastroenterology.

[5]  N. Kapel,et al.  Faecal Calprotectin in Term and Preterm Neonates , 2010, Journal of pediatric gastroenterology and nutrition.

[6]  J. Tyson,et al.  Altered fecal microflora and increased fecal calprotectin in infants with colic. , 2009, The Journal of pediatrics.

[7]  I. Dale,et al.  Release and Quantitation of a Leucocyte Derived Protein (L1) , 2009 .

[8]  L. Hansson,et al.  Colorectal Inflammation is Well Predicted by Fecal Calprotectin in Children with Gastrointestinal Symptoms , 2005, Journal of pediatric gastroenterology and nutrition.

[9]  A. M. van den Neucker,et al.  Fecal calprotectin in healthy term and preterm infants. , 2004, Journal of pediatric gastroenterology and nutrition.

[10]  L. Hansson,et al.  Fecal Calprotectin Levels in Healthy Children Studied With an Improved Assay , 2003, Journal of pediatric gastroenterology and nutrition.

[11]  S. Bunn,et al.  Age‐Dependent Variations in Fecal Calprotectin Concentrations in Children , 2002, Journal of Pediatric Gastroenterology and Nutrition.

[12]  M. Fagerhol,et al.  Age-dependent variations in fecal calprotectin concentrations in children. , 2002, Journal of pediatric gastroenterology and nutrition.

[13]  A. Berstad,et al.  Faecal calprotectin levels in infants with infantile colic, healthy infants, children with inflammatory bowel disease, children with recurrent abdominal pain and healthy children , 2002, Acta paediatrica.

[14]  S. Bunn,et al.  Fecal Calprotectin as a Measure of Disease Activity in Childhood Inflammatory Bowel Disease , 2001, Journal of pediatric gastroenterology and nutrition.

[15]  H. Schjønsby,et al.  Improved assay for fecal calprotectin. , 2000, Clinica chimica acta; international journal of clinical chemistry.

[16]  A. Røseth,et al.  High prevalence of NSAID enteropathy as shown by a simple faecal test , 1999, Gut.

[17]  A. Røseth,et al.  Correlation between faecal excretion of indium-111-labelled granulocytes and calprotectin, a granulocyte marker protein, in patients with inflammatory bowel disease. , 1999, Scandinavian journal of gastroenterology.

[18]  T. Lyberg,et al.  Functional and clinical aspects of the myelomonocyte protein calprotectin. , 1997, Molecular pathology : MP.

[19]  J. Jahnsen,et al.  Assessment of disease activity in ulcerative colitis by faecal calprotectin, a novel granulocyte marker protein. , 1997, Digestion.

[20]  B. Roald,et al.  Faecal calprotectin: a novel test for the diagnosis of colorectal cancer? , 1993, Scandinavian journal of gastroenterology.

[21]  A. Røseth,et al.  Assessment of the neutrophil dominating protein calprotectin in feces. A methodologic study. , 1992, Scandinavian journal of gastroenterology.

[22]  P. Brandtzaeg,et al.  Distribution of a new myelomonocytic antigen (L1) in human peripheral blood leukocytes. Immunofluorescence and immunoperoxidase staining features in comparison with lysozyme and lactoferrin. , 1985, American journal of clinical pathology.